PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
- Conditions
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 500
- Registration Number
- NCT06646471
- Locations
- 🇫🇷
CH du Pays d Aix, Aix En Provence, France
🇫🇷Hôpital Henri Duffaut, Avignon, France
🇫🇷CH Bastia, Bastia, France
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 45
- Registration Number
- NCT06620835
- Locations
- 🇫🇷
CHU de Brest, Brest, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷CH Métropole-Savoie, Chambery, France
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
- Conditions
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 30
- Registration Number
- NCT06247826
- Locations
- 🇫🇷
Pneumologie, Hôpital Tenon, Paris, France
🇫🇷Oncologie Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
🇫🇷Centre Hospitalier du Morvan, Brest, France
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 200
- Registration Number
- NCT05308966
- Locations
- 🇫🇷
Hôpital Ambroise Paré, Boulogne-Billancourt, France
🇫🇷CHU Caen, Caen, France
🇫🇷CH Annecy Genevois, Pringy, France
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
- Conditions
- Interventions
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 100
- Registration Number
- NCT05122806
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Oncologie CLCC Jean Perrin, Clermont-Ferrand, France
🇫🇷Pneumologie Hôpital Mignot, Le Chesnay, France
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
- Conditions
- Interventions
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 413
- Registration Number
- NCT05049044
- Locations
- 🇫🇷
Hôpital du Scorff, Lorient, France
🇫🇷Centre Hospitalier Intercommunal de Quimper, Quimper, France
🇫🇷Institut Lucien Neuwirth, Saint-Priest-en-Jarez, France
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
- Conditions
- First Posted Date
- 2017-10-09
- Last Posted Date
- 2020-03-12
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 86
- Registration Number
- NCT03305133
- Locations
- 🇫🇷
Site 05, Bastia, France
🇫🇷Site 43, Caen, France
🇫🇷Site 48, Clermont Ferrand, France
Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
- First Posted Date
- 2016-05-30
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 170
- Registration Number
- NCT02785562
- Locations
- 🇫🇷
Centre Hospitalier Les Oudairies, La Roche Sur Yon, France
🇫🇷Site 04, GAP, France
🇫🇷Centre Hospitalier Universitaire DUPUYTREN, Limoges, France
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)
- Conditions
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 144
- Registration Number
- NCT02293733
- Locations
- 🇫🇷
Centre Hospitalier du Morvan, Brest, France
🇫🇷Centre Hospitalier D Argenteuil, Argenteuil, Val D'oise, France
🇫🇷Site 12, Aix En Provence, France
Feasibility of re Biopsies at Progression
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 100
- Registration Number
- NCT02086071
- Locations
- 🇫🇷
Centre Hospitalier du Morvan, Brest, France
🇫🇷Site 20, Rennes, France
🇫🇷Centre Hospitalier Universitaire, Angers, France